1.Muto, CA, Jerigan, JA, Ostrowsky, BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362–386.
2. Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association: revised methicillin-resistant Staphylococcus aureus infection control guidelines for hospitals. 1999. Available at: http://www.his.org.uk/. Accessed May 2004.
3.Garner, JS and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:53–80.
4.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the Appropriateness Evaluation Protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987; 25:481–488.
5.Zoutman, D, McDonald, S, Vethanayagan, D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care centre. Infect Control Hosp Epidemiol 1998; 19:254–259.
6.Vilella, A, Prat, A, Trilla, A, Bayas, JM, Asenjo, MA, Salleras, L. Excess length of stay attributable to nosocomial bacteraemia: usefulness of the Hospitalization Appropriateness Protocol. Med Clin (Bare) 1999; 113:608–610.
7.Kim, T, Oh, PI, Simor, AW. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99–104.
8.Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126–132.
9.Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Reginer, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission on the intensive care unit. Arch Intern Med 2003; 163:181–188.